Application

19222083 · GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES

Filed 2025-05-29 · Pending The official file ↗ · Art unit 1631 · Examiner Jianjian Zhu Typical · CPC A61P 35/00 · BlueRock Therapeutics LP · ALSTON & BIRD LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

1.3 mo

to disposition n/a

Statutes raised

103 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.